| abstract |
The invention provides for the use of the substituted isethionate ester: RCOO-CHR1-CHR2-SO3M wherein M is a monovalent cation or equivalent thereof, R is alkyl, R1 is hydrogen or alkyl and R2 is hydrogen or alkyl, provided that R1 and R2 are not both hydrogen, in medicine and for the manufacture of a medicament for use in the treatment or prophylacsis of erythema. The invention also extends to a method for the cosmetic treatment of the human body which includes the step of treating the surface of the skin with a composition including the substituted isethionate ester and further extends to compositions comprising the substituted isethionate ester and at least 20 % water. |